The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier denial by the U.S. District Court for the Southern District of Mississippi of preliminary injunctions sought by Novartis and PhRMA against enforcement of the state's 340B contract pharmacy law. The law preserves 340B discounts for drugs dispensed at community pharmacies. 

The AHA also filed friend-of-the-court briefs in the Southern District of Mississippi prior to the court’s denial of the injunctions in July. The AHA has filed briefs in similar cases elsewhere, including in the U.S. Court of Appeals for the 8th Circuit, which upheld a similar law in Arkansas.
 
Joining AHA in the Nov. 15 filings were 340B Health, the Mississippi Hospital Association, the Rural Hospital Alliance and the American Society for Health-system Pharmacists.

Related News Articles

Headline
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation…
Headline
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from…
Headline
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state’s law protecting 340B pricing for contract pharmacy arrangements. The…
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…
Headline
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory…
Headline
The AHA March 10 filed a friend-of-the-court brief in the U.S. District Court for the Northern District of Illinois, urging the court to oppose a motion by…